Checkpoint Inhibition in Myeloma: Opportunities and Challenges

Despite major improvements in the treatment landscape, most multiple myeloma (MM) patients eventually succumb to the underlying malignancy. Immunotherapy represents an attractive strategy to achieve durable remissions due to its specificity and capacity for long term memory. Activation of immune cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Costa, Federica, Das, Rituparna, Kini Bailur, Jithendra, Dhodapkar, Kavita, Dhodapkar, Madhav V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168958/
https://www.ncbi.nlm.nih.gov/pubmed/30319648
http://dx.doi.org/10.3389/fimmu.2018.02204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168958/
https://www.ncbi.nlm.nih.gov/pubmed/30319648
http://dx.doi.org/10.3389/fimmu.2018.02204

Ejemplares similares